Severity
Critical
FDA Drug recall · Reported February 28, 2024
Chemical Contamination; presence of benzene.
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalled TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) c… - a critical-severity action.
TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) c… was recalled by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company in February 28, 2024. Reason: Chemical Contamination; presence of benzene.. Check the official notice for the remedy. Verify recall #D-0346-2024 with the FDA Drug before acting.
The recall
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company issued this critical-severity FDA Drug recall-Chemical Contamination; presence of benzene..
Sourced from official FDA Drug enforcement records. Verify recall #D-0346-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0346-2024) was formally reported on February 28, 2024, with the manufacturer initiating the action on February 1, 2024. It is classified under Critical severity (Class I), with a current status of Completed. Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company is listed as the recalling firm, operating out of Tarrytown, NY. Federal records list the affected scope as 59,644 cans.
The documented reason for this recall is: Chemical Contamination; presence of benzene. Distribution data in the federal record shows the product reached: Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
59,644 cans
Related Recalls
6
5 from same agency
TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591 UPC 3 63736 81961 3
Chemical Contamination; presence of benzene.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Completed |
| Recall number | D-0346-2024 |
| Date reported | February 28, 2024 |
| Date initiated | February 1, 2024 |
| Recalling firm | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company |
| Firm location | Tarrytown, NY |
| Affected scope | 59,644 cans |
| Distribution | Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 28, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.